Physician profile
Ross M Hogan
NPI 1255591285
$3,316.61
in general payments reported to CMS, 2019-2025
37 companies · $546 in 2025
The $546 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $408 · 2021: $478 · 2022: $377 · 2023: $656 · 2024: $489 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,690.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $774.94 | 2019-2024 | Resonance, Fiber Dust, Litho 150 |
| Sumitomo Pharma America, INC. | $634.16 | 2023-2025 | Gemtesa |
| Abbvie INC. | $189.10 | 2019-2025 | |
| Tolmar, INC. | $177.75 | 2023-2025 | Jatenzo, Eligard |
| Procept Biorobotics Corporation | $170.23 | 2020-2023 | Aquabeam Robotic System |
| Teleflex LLC | $150.84 | 2021 | |
| Medtronic USA, INC. | $113.52 | 2020 | |
| Astellas Pharma US INC | $97.61 | 2019-2023 | Myrbetriq |
| Myriad Genetic Laboratories, INC. | $96.25 | 2021-2023 | Prolaris |
| Rochester Medical Corporation | $86.69 | 2021-2022 | |
| Janssen Biotech, INC. | $80.39 | 2019-2025 | Erleada |
| Allergan, INC. | $64.36 | 2021 | |
| Pfizer INC. | $61.23 | 2024-2025 | |
| Antares Pharma, INC. | $57.58 | 2020-2022 | |
| Urovant Sciences INC | $53.53 | 2022 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.